Allied Market Research published a report, titled, 'Continuous Renal Replacement Therapy Market by Product (Dialysates and Replacement Fluids, Disposables, CRRT Systems), by Modality (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Haemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF)), by Age Group (Adults, Pediatrics): Global Opportunity Analysis and Industry Forecast, 2022-2031.' According to the report, the global continuous renal replacement therapy industry amassed a sum of $1.3 billion in 2021, and is estimated to garner $2.6 billion by 2031, witnessing a CAGR of 7.7% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.
Drivers and Opportunities
Surge in prevalence of kidney-related diseases, demand for continuous renal replacement therapy, rise in geriatric population, and increase in technologically advanced CRRT products for pediatrics drive the growth of the global continuous renal replacement therapy market. However, high cost associated with CRRT devices and the lack of awareness regarding continuous renal replacement therapy in developing countries due to inadequate funding, poor healthcare infrastructure, insufficient human resources, and geographic distance hamper the market growth. On the other hand, rise in government initiatives for regulatory approval of CRRT offer potential opportunities for the market growth.
Download Sample Report - https://www.alliedmarketresearch.com/request-sample/12288
Covid-19 Scenario
- The COVID-19 pandemic impacted the continuous renal replacement therapy market positively, owing to a significant rise in global demand for renal replacement fluids (RRT). The early initiation of continuous renal replacement therapy (CRRT) was an important step in curbing the growing prevalence of acute kidney injury (AKI) due to the COVID-19 infection.
- Owing to the surge in demand for CRRT worldwide, the market for CRRT saw an increase in financial incentives and regulatory support from various government agencies.
- The pandemic also created opportunities for local manufacturers who are adopting various plans and policies to gain a higher market share.
Get detailed COVID-19 impact analysis on the Continuous Renal Replacement Therapy Market - https://www.alliedmarketresearch.com/request-for-customization/12288?reqfor=covid
The dialysates and replacement fluids segment to rule the roost during the forecast period
Based on product, the dialysates and replacement fluids segment was the largest market in 2021, contributing to nearly three-fifths of the global continuous renal replacement therapy market, and is expected to maintain its leadership status during the forecast period. The same segment is projected to witness the fastest CAGR of 8.1% from 2022 to 2031. This is attributed to rise in the incidence of acute kidney injury which has increased the demand for continuous renal replacement therapy.
The continuous venovenous hemofiltration (CVVH) segment to maintain its leadership status during the forecast period
Based on modality, the continuous venovenous hemofiltration (CVVH) segment held nearly one-third of the global continuous renal replacement therapy market share in 2021, and is expected to maintain its leadership status during the forecast period. CVVH is widely used to remove large volumes of fluid while avoiding the hypotensive episodes caused by intermittent hemodialysis. However, the continuous venovenous hemodiafiltration (CVVHDF) segment is projected to witness the highest CAGR of 8.4% from 2022 to 2031. CVVHD is an effective treatment for patients suffering from acute renal failure.
The adults segment to lead the trail during the forecast period
Based on age group, the adults segment contributed to nearly two-thirds of the global continuous renal replacement therapy market in 2021 and is expected to maintain its dominance during the forecast period. The same segment is projected to witness the fastest CAGR of 8.0% from 2022 to 2031. The growth of the segment is attributed to various regulatory approvals for the adult CRRT, and rise in development of novel products for CRRT. Along with this, adoption of several growth strategies by the market players create lucrative opportunities in the segment.
For Purchase Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/12288
Asia-Pacific to maintain its lead position during the forecast period
Based on region, the market in Asia-Pacific held the largest market share of around one-third of the global continuous renal replacement therapy market in 2021, and is expected to maintain its lead position during the forecast period. The same segment is projected to manifest the fastest CAGR of 8.8% from 2022 to 2031. This is primarily attributed to the increase in number of initiatives along with rise in investments in R&D of CRRT products. In addition, increased focus of leading manufacturers on expanding their geographical presence and rise in healthcare expenditure drives the growth in the region.
Leading Market Players
- Fresenius Medical Care
- Baxter International
- Toray Industries Inc.
- SWS Hemodialysis Care
- Nipro Corporation
- Ningbo Tianyi Medical Devices
- NIKKISO Co. Ltd.
- Medtronic Plc.
- Medites Pharma spol. s.r.o
- Medical Components Inc.
- Medica S.p.A
- Infomed SA
- Cytosorbents
- Chongqing Shanwaishan Science and Technology
- B. Braun Melsungen Ag
- Asahi Kasei Corporation
- Anjue Medical Equipment Co. Ltd.
The report analyzes these key players of the global continuous renal replacement therapy market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
Official Press Release - https://www.alliedmarketresearch.com/press-release/continuous-renal-replacement-therapy-market.html
Similar Research Reports
Continuous Renal Replacement Therapy market-- https://www.alliedmarketresearch.com/continuous-renal-replacement-therapy-market-A11923
Healthcare Gamification Market-- https://www.alliedmarketresearch.com/healthcare-gamification-market-A11002
AVENUE - A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
According to the report, the global continuous renal replacement therapy market was valued at ~US$ 865 Mn in 2018, and is projected to expand at a CAGR of ~7% during the forecast period.Global Continuous Renal Replacement Therapy Market: OverviewContinuous renal replacement therapy (CRRT) is a preferred modality for managing hemodynamically patients suffering from acute kidney injury.
Moreover, surge in the number of dialysis centers across the world is expected to propel the global continuous renal replacement therapy market.Europe dominated the global continuous renal replacement therapy market in 2018, and the trend is anticipated to continue during the forecast period.
However, shortage of trained staff and high cost of CRRT systems are likely to hamper the continuous renal replacement therapy market in the region during the forecast period.Asia Pacific is expected to be a highly lucrative continuous renal replacement therapy market during the forecast period, owing to increasing healthcare infrastructure, along with rise in the incidence of acute kidney injury in the region.Request COVID Analysis on Continuous Renal Replacement Therapy Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=10298 Rise in Incidence of Diabetes and Hypertension to Drive MarketIncreasing incidence of chronic diseases, such as diabetes and hypertension, fuels the risk of developing acute kidney injury.
Hypertension causes around 9.4 million deaths globally every year.
The development of fourth-generation continuous renal replacement therapy devices, such as ACUsmart, offers a smart and optimal device for critically-ill patients.Continuous Venovenous Haemofiltration (CVVH) Mode to Lead CRRT Market Continuous venovenous hemofiltration (CVVHF) is the most preferred technique.
CVVH is more effective than continuous venovenous haemodiafiltration (CVVHDF), and may be associated with fewer complications.
Continuous Renal Replacement Therapy Market" Continuous Renal Replacement Therapy Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022" ", published by MarketsandMarkets™, The global CRRT market is estimated to reach USD 1.53 billion by 2022; growing at a CAGR of 7.0% during the forecast period.Don’t miss out on business opportunities in Continuous Renal Replacement Therapy MarketIncreasing prevalence of AKI and renal disorders, growing number of ICU patients, rapid growth in the aging population, and clinical advantages of CRRT over intermittent blood purification techniques are some key factors propelling the growth of this market.Continuous Renal Replacement Therapy Market : Target AudienceCRRT manufacturers, suppliers, and distributorsCRRT service providersRenal research laboratoriesRenal associations and organizationsHospitals and critical care unitsAcademic medical centers and universitiesBusiness research and consulting service providersBrowse and in-depth TOC on "NGS Sample Preparation Market" 121 - Tables40 - Figures203 - PagesTo know about the assumptions considered for the study, download the pdf brochureGrowing demand of hemofilters to drive the global CRRT market to reach USD 1.53 billion by 2022Hemofilters or artificial kidneys are one of the major components in a CRRT system.
These filters usually contain a semipermeable membrane in a hollow-fiber design.
This design enables blood to flow inside the hollow fibers and, at the same time, allows the dialysate to flow outside the fibers.
The membrane type and surface area help to determine solute and fluid removal during a CRRT procedure.Continuous Renal Replacement Therapy Market : Key QuestionsWhat are the key growth strategies adopted by major continuous renal replacement therapy market players to maintain their market position across key geographies?What is the existing developmental pipeline of major modalities among key CRRT manufacturers?Growing number of Acute Kidney Injury (AKI) patients is a key trend in CRRT market.
What impact AKI incidences will have on CRRT market during the forecast period?What alternative technologies/therapies are currently being used for AKI worldwide?
What competition they pose for key CRRT market players.
